Global Key SolutionsGKS
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Four Elements Organic Herbals, LLC
WARNING LETTER
•Four Elements Organic Herbals, LLC•May 21, 2014

FDA WARNING_LETTER - Four Elements Organic Herbals, LLC - May 21, 2014

View on Dashboard

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents
Record Details

The FDA conducted an inspection of Four Elements Organic Herbals, LLC from April 25 to May 21, 2014, and reviewed their websites in May and August 2014. The FDA determined that products such as HERBAL TEA Power, Energy & Stamina, ORGANIC HERBAL TEA Tulsi TelepaTea, and others, are unapproved new drugs and misbranded.

Violations include claims on product labels and websites establishing the products as drugs intended for disease treatment, mitigation, cure, or prevention, or to affect body structure/function, violating sections 201(g)(1)(B) and 201(g)(1)(C) of the Federal Food, Drug, and Cosmetic Act (the Act). Examples of drug claims include treating diabetes, high blood pressure, asthma, reducing cholesterol, and healing wounds.

These products are considered "new drugs" under section 201(p) of the Act because they are not generally recognized as safe and effective for their intended uses. Introducing new drugs into interstate commerce without FDA approval violates sections 301(d) and 505(a). Additionally, several products are misbranded under section 502(f)(1) because they lack adequate directions for use by a layperson, as they are intended for conditions not amenable to self-diagnosis or treatment.

The company must take prompt action to correct these violations and notify the

Company
Four Elements Organic Herbals, LLC
Inspection Date
May 21, 2014
Product Type
Drugs
Office
Minneapolis District Office
Person
  • Michael Dutcher (Acting Assistant Commissioner)
Open in Dashboard

ID · 6bdfb590-aab8-4f8e-ac6a-634631456449

Violation Codes9
21 U.S.C. 331(a)21 U.S.C. 321(g)(1)(B)21 U.S.C. 321(g)(1)(C)21 U.S.C. 321(p)21 U.S.C. 331(d)21.U.S.C. 355(a)21 U.S.C. 352(f)(1)21 CFR 201.521 U.S.C. 353(b)(1)(A)

Full citation text and observation details available on the Dashboard.

footer
Global Key Solutions
Regulatory Data Transformed
Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
[email protected]
Quick Links
KeyPedia™ Lite
Legal & Ethics
©2026, Global Key Solutions All rights reserved.